Profil

LEDUC Stéphane

Unilab > Laboratoire Cytogénétique

See author's contact details
Main Referenced Co-authors
Boemer, François  (3)
Bours, Vincent  (2)
Jerusalem, Guy  (2)
Josse, Claire  (2)
Onesti, Concetta Elisa  (2)
Main Referenced Unit & Research Centers
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège [BE] (1)
Main Referenced Disciplines
Oncology (2)
Reproductive medicine (gynecology, andrology, obstetrics) (1)

Publications (total 3)

The most downloaded
50 downloads
ONESTI, C. E., BOEMER, F., JOSSE, C., LEDUC, S., BOURS, V., & JERUSALEM, G. (2019). Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy. Journal of Translational Medicine, 17, 239. doi:10.1186/s12967-019-1984-2 https://hdl.handle.net/2268/240021

The most cited

33 citations (Scopus®)

ONESTI, C. E., BOEMER, F., JOSSE, C., LEDUC, S., BOURS, V., & JERUSALEM, G. (2019). Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy. Journal of Translational Medicine, 17, 239. doi:10.1186/s12967-019-1984-2 https://hdl.handle.net/2268/240021

NEEMA UFOYMUNGU, Y., JUAKALI SIHALIKYOLO, J. J., Marini Djang'Eing'A, R., KATENGA BOSUNGA, G., Avohou, T. H., LEDUC, S., BOEMER, F., & BATINA AGASA, S. (2020). Performance of Sickle SCAN® in the Screening of Sickle Cell Disease in Kisangani Pregnant Women and Attitude towards Results. Open Journal of Blood Diseases. doi:10.4236/ojbd.2020.102003
Peer reviewed

ONESTI, C. E., BOEMER, F., JOSSE, C., LEDUC, S., Poulet, C., BOURS, V., & JERUSALEM, G. (2019). Tryptophan catabolism differentiates breast cancer patients from healthy controls but does not predict outcome. Annals of Oncology.
Peer Reviewed verified by ORBi

ONESTI, C. E., BOEMER, F., JOSSE, C., LEDUC, S., BOURS, V., & JERUSALEM, G. (2019). Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy. Journal of Translational Medicine, 17, 239. doi:10.1186/s12967-019-1984-2
Peer Reviewed verified by ORBi

Contact ORBi